Your employees walk away from the pharmacy counter every day with prescriptions they never fill. You already covered the office visit. You already negotiated the benefit. The drug is sitting on a shelf somewhere, waiting. And the cost of whatever happens next lands squarely on your plan.
Prescription abandonment is not a patient education problem. It is a benefits problem. And right now, it is getting worse.
Roughly 27% of all prescriptions in the United States go unfilled, with abandonment rates climbing to 67% at the pharmacy counter when out-of-pocket costs exceed $250, according to IQVIA 2025 data. For a benefits leader, that number deserves a second read. Two out of three employees facing a meaningful cost at the pharmacy will walk away from their medication entirely, not call HR, not appeal the claim, not ask for help. They just leave.
The timing makes this particularly urgent. Employers are projecting pharmacy costs to rise 11 to 12% in 2025 into 2026, with pharmacy expenses already accounting for 24% of total health care dollars in 2024, according to the Business Group on Health. Plans are spending more. Members are still abandoning therapy. The gap between investment and outcome is widening, and most of it never shows up in a claims report.
The Complaint You Never Receive
Here is what makes abandonment so difficult to manage: it is silent. When an employee has a coverage dispute, they call. When a claim is denied, they escalate. But when they walk away from a $300 prescription, they say nothing. They simply stop taking the medication. Weeks or months later, something else happens. An emergency visit. A worsening condition. A productivity dip that no one connects back to a drug that was never started.
When a patient abandons therapy, the real cause often remains unclear. Benefits teams are left managing downstream noise without visibility into the original breakdown. That is a structural problem, not a communication failure.
The pattern is consistent across drug categories and member populations. Abandonment rates reach 34% for Medicaid members, 24% for Medicare, and 28% for commercial populations, with specialty drugs driving the steepest drop-off. The members most likely to abandon are often managing the most serious conditions. They are also the least likely to ask for help.
Cost-Sharing Is Not a Neutral Lever
When pharmacy costs rise, the instinctive response is to shift more cost to members. It feels like a rational design choice. Half of large employers said they are likely or very likely to make plan design changes that shift more cost to employees in 2026, up from 45% the prior year, according to Mercer’s Survey on Health and Benefit Strategies for 2026. But every point of additional cost-sharing at the pharmacy counter carries a hidden tax: the members who cannot absorb it abandon therapy, and the downstream medical spend follows.
This is not a theoretical concern. Research connecting out-of-pocket thresholds to abandonment is consistent. The pharmacy counter is where benefit design decisions produce real clinical and financial consequences, and most of those consequences are invisible until they are expensive.
What Benefits Leaders Actually Need
The abandonment problem does not resolve itself through better communications, clearer EOBs, or a new app for employees to download. Those approaches reach the members who are already engaged. The members walking away from the pharmacy counter are not disengaged by choice. They are responding rationally to a system that gave them a cost they were not prepared to pay.
What reduces abandonment is what the member never has to experience at all. When the prescribing physician understands the cost options with therapeutic alternatives flagged for them, the patient benefits. The prescription becomes something the patient can afford to fill.
That is a physician-side intervention, not a member-side one. And it is the difference between a benefit that performs and a benefit that just exists.
The prescriptions your plan already paid for deserve to get filled. The question is whether your current approach makes that likely, or just possible. Contact RazorMetrics today to optimize your plan’s performance.
